Annual accounts receivable:
$4.36B+$309.48M(+7.65%)Summary
- As of today (August 17, 2025), TAK annual accounts receivable is $4.36 billion, with the most recent change of +$309.48 million (+7.65%) on March 1, 2025.
- During the last 3 years, TAK annual accounts receivable has fallen by -$731.56 million (-14.38%).
- TAK annual accounts receivable is now -31.96% below its all-time high of $6.40 billion, reached on March 31, 2021.
Performance
TAK Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$4.60B-$547.06M(-10.62%)Summary
- As of today (August 17, 2025), TAK quarterly accounts receivable is $4.60 billion, with the most recent change of -$547.06 million (-10.62%) on June 1, 2025.
- Over the past year, TAK quarterly accounts receivable has dropped by -$89.37 million (-1.90%).
- TAK quarterly accounts receivable is now -40.00% below its all-time high of $7.67 billion, reached on December 31, 2020.
Performance
TAK Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
TAK Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.7% | -1.9% |
| 3 y3 years | -14.4% | -17.5% |
| 5 y5 years | -29.9% | -36.9% |
TAK Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.4% | +7.7% | -17.5% | +1.6% |
| 5 y | 5-year | -32.0% | +7.7% | -40.0% | +1.6% |
| alltime | all time | -32.0% | +154.9% | -40.0% | +36.5% |
TAK Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $4.60B(-10.6%) |
| Mar 2025 | $4.36B(+7.6%) | $5.15B(+13.7%) |
| Dec 2024 | - | $4.53B(-7.6%) |
| Sep 2024 | - | $4.91B(+4.5%) |
| Jun 2024 | - | $4.69B(-1.1%) |
| Mar 2024 | $4.05B(-6.4%) | $4.75B(-6.5%) |
| Dec 2023 | - | $5.08B(+0.4%) |
| Sep 2023 | - | $5.06B(-7.7%) |
| Jun 2023 | - | $5.48B(+8.1%) |
| Mar 2023 | $4.32B(-15.0%) | $5.06B(-6.1%) |
| Dec 2022 | - | $5.39B(+2.6%) |
| Sep 2022 | - | $5.26B(-5.7%) |
| Jun 2022 | - | $5.58B(-4.1%) |
| Mar 2022 | $5.09B(-20.5%) | $5.82B(-6.4%) |
| Dec 2021 | - | $6.22B(-17.5%) |
| Sep 2021 | - | $7.54B(+0.7%) |
| Jun 2021 | - | $7.48B(+4.7%) |
| Mar 2021 | $6.40B(+3.1%) | $7.15B(-6.9%) |
| Dec 2020 | - | $7.67B(+7.6%) |
| Sep 2020 | - | $7.13B(-2.2%) |
| Jun 2020 | - | $7.29B(+10.2%) |
| Mar 2020 | $6.21B(+4.6%) | $6.62B(-12.2%) |
| Dec 2019 | - | $7.54B(+4.4%) |
| Sep 2019 | - | $7.22B(+2.5%) |
| Jun 2019 | - | $7.05B(+11.8%) |
| Mar 2019 | $5.94B(+75.1%) | $6.30B(+36.5%) |
| Dec 2018 | - | $4.62B(+13.8%) |
| Sep 2018 | - | $4.06B(-0.5%) |
| Jun 2018 | - | $4.08B(+17.3%) |
| Mar 2018 | $3.39B(+6.1%) | $3.48B(-23.4%) |
| Dec 2017 | - | $4.54B(+9.5%) |
| Sep 2017 | - | $4.15B(+4.4%) |
| Jun 2017 | - | $3.97B(+4.9%) |
| Mar 2017 | $3.20B(-4.5%) | $3.79B(-10.2%) |
| Dec 2016 | - | $4.22B(-2.2%) |
| Sep 2016 | - | $4.31B(+3.9%) |
| Jun 2016 | - | $4.15B(+12.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | $3.35B(+0.2%) | $3.70B(-8.0%) |
| Dec 2015 | - | $4.02B(+2.1%) |
| Sep 2015 | - | $3.94B(+4.7%) |
| Jun 2015 | - | $3.76B(+1.5%) |
| Mar 2015 | $3.34B(-8.4%) | $3.70B(-9.5%) |
| Dec 2014 | - | $4.09B(-1.6%) |
| Sep 2014 | - | $4.16B(-0.7%) |
| Jun 2014 | - | $4.19B(+0.2%) |
| Mar 2014 | $3.65B(+0.2%) | $4.18B(+2.6%) |
| Dec 2013 | - | $4.08B(+3.4%) |
| Sep 2013 | - | $3.94B(+5.8%) |
| Jun 2013 | - | $3.73B(-6.4%) |
| Mar 2013 | $3.64B(-12.3%) | $3.98B(-10.0%) |
| Dec 2012 | - | $4.42B(+2.7%) |
| Sep 2012 | - | $4.31B(-0.8%) |
| Mar 2012 | $4.15B(+17.5%) | $4.34B(+28.6%) |
| Mar 2011 | $3.54B(+18.1%) | $3.37B(-10.5%) |
| Mar 2010 | $2.99B(-1.9%) | - |
| Mar 2009 | $3.05B(+22.8%) | - |
| Dec 2008 | - | $3.77B |
| Mar 2008 | $2.48B(+12.2%) | - |
| Mar 2007 | $2.21B(+10.5%) | - |
| Mar 2006 | $2.00B(-4.9%) | - |
| Mar 2005 | $2.11B(+4.5%) | - |
| Mar 2004 | $2.02B(+18.0%) | - |
| Mar 2003 | $1.71B(-3.6%) | - |
| Mar 2002 | $1.77B(-12.6%) | - |
| Mar 2001 | $2.03B(-10.9%) | - |
| Mar 2000 | $2.28B(+19.5%) | - |
| Mar 1999 | $1.91B(+10.3%) | - |
| Mar 1998 | $1.73B(-14.0%) | - |
| Mar 1997 | $2.01B(-17.1%) | - |
| Mar 1996 | $2.42B(-13.7%) | - |
| Mar 1995 | $2.81B(+25.4%) | - |
| Mar 1994 | $2.24B(+22.6%) | - |
| Mar 1993 | $1.83B(-1.7%) | - |
| Mar 1992 | $1.86B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual accounts receivable?
- What is the all time high annual accounts receivable for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual accounts receivable year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly accounts receivable year-on-year change?
What is Takeda Pharmaceutical Company Limited annual accounts receivable?
The current annual accounts receivable of TAK is $4.36B
What is the all time high annual accounts receivable for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual accounts receivable is $6.40B
What is Takeda Pharmaceutical Company Limited annual accounts receivable year-on-year change?
Over the past year, TAK annual accounts receivable has changed by +$309.48M (+7.65%)
What is Takeda Pharmaceutical Company Limited quarterly accounts receivable?
The current quarterly accounts receivable of TAK is $4.60B
What is the all time high quarterly accounts receivable for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly accounts receivable is $7.67B
What is Takeda Pharmaceutical Company Limited quarterly accounts receivable year-on-year change?
Over the past year, TAK quarterly accounts receivable has changed by -$89.37M (-1.90%)